Clinical Trial

Study of DCC-2618 in Patients With GIST After at Least 3 Prior Treatments

Name: Study of DCC-2618 in Patients With GIST After at Least 3 Prior Treatments — clinical trial record (NCT07618377)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

To evaluate the safety of DCC-2618 in patients with unresectable, metastatic, or recurrent gastrointestinal stromal tumor (GIST) who have received three or more prior therapies

Protocol Amendment History 1 change

critical Recruitment opened 2026-07-21

Trial Details

NCT Number	NCT07618377
Lead Sponsor	Ono Pharmaceutical Co., Ltd.
Conditions	Gastrointestinal Stromal Tumors
Enrollment	10 participants
Start Date	2026-07-07
Primary Completion	2028-02 (estimated)
Study Completion	2028-02 (estimated)
Updated on ClinicalTrials.gov	2026-07-20